Hint mode is switched on Switch off
For swift navigation between sections

Organization: Amgen
LEI 62QBXGPJ34PQ72Z12S66

Organization name
Amgen, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
63,656 mln USD

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Awards

Documentation

Stocks

Latest issues

Bond debt by currency

Codes

  • LEI
    62QBXGPJ34PQ72Z12S66
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • ICB
    4,500 Health Care
  • CIK
    0000318154
  • EIN
    95-3540776

Credit and ESG Ratings

Macroeconomic Indicators - Amgen

Registration is required to get access.